Gastric Castleman's Disease with a Lupus-like Circulating Anticoagulant

Yebra, M.; Vargas, J. A.; Menéndez, M. J.; Cabrera, J. R.; Díaz, F.; Diego, F. J.; Durántez, A.
May 1989
American Journal of Gastroenterology;May1989, Vol. 84 Issue 5, p566
Academic Journal
We report the case of a 13-yr-old patient with retarded growth and a 2-yr background of asthenia, anorexia, and fever, whose laboratory data revealed anemia, thrombocytosis, an elevated erythrocyte sedimentation rate, ferropenia, hyperglobulinemia, hyperfibrinogenemia, and presence of a lupus-like circulating anticoagulant. Clinical studies revealed a tumor-like overgrowth in the gastric wall, and surgery confirmed its subserosal localization in the gastric fundus. After total removal of the mass, the systemic manifestations disappeared. The pathological study revealed the existence of the hyaline-vascular variety of Castleman's disease. Having reviewed the medical literature, we have not found a single unquestionable case of gastric Castleman's disease, although three other cases have been described as gastric psendolymphoma which, when analyzed, could correspond to typical cases of Castleman's disease. Likewise, this is the second case associated with a circulating anticoagulant of lupoid characteristics. We conclude that Castleman's disease should be included in the differential diagnosis of gastric lesions of lymphoid nature and in the series of processes associated with lupus anticoagulant.


Related Articles

  • Coagulation disorders and anti-coagulants. Bansal, Pranav; Jain, gaurav // Anaesthesia, Pain & Intensive Care;Oct-Dec2011, Vol. 15 Issue 3, p198 

    A quiz concerning blood coagulation disorders and anti-coagulants in the management of patients with neuraxial block is presented.

  • thrombolymphangitis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2313 

    A definition of the term "thrombolymphangitis," which refers to inflammation of a lymphatic vessel due to obstruction by thrombus formation, is presented.

  • Inflammation and Coagulation: Implications for the Septic Patient. Dellinger, R. Phillip // Clinical Infectious Diseases;5/15/2003, Vol. 36 Issue 10, p1259 

    Sepsis with acute organ dysfunction (severe sepsis) is common, frequently fatal, and associated with a significant national health/economic burden. In addition to standard care, investigators have focused on interrupting the inflammatory and anti-inflammatory cascade associated with this...

  • Clinical and Genetic Aspects of Coagulopathies. Koller, Fritz // Annals of Internal Medicine;Apr65, Vol. 62 Issue 4, p744 

    Focuses on the clinical and genetic aspects of blood coagulation disorders. Deficiency of clotting factors in hereditary and acquired coagulopathies; Hemophilia in royal families in Europe; Potentiation of anticoagulant effect of dicoumarol derivative by phenylbutazone.

  • Primena trombinskog praha posle ekstrakcije zuba kod bolesnika koji primaju antikoagulantnu terapiju. Marjanovic, Marjan // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Jul/Aug2002, Vol. 59 Issue 4, p389 

    Patients with extreme hypocoagulation, which occurs either as an effect of some diseases with coagulation deficiency or because of the anticoagulant therapy (ACT), are a risk group for oral surgery. In the last decades decision to change or interrupt ACT before and after the procedure was...

  • THE ANTITHROMBOTIC PROPERTIES OF COUMARIN DRUGS. Hoak, John C.; Connor, William E.; Warner, Emory D.; Carter, John R. // Annals of Internal Medicine;Jan61, Vol. 54 Issue 1, p73 

    Studies the association between clotting factor deficiencies and prolongation of the whole blood silicone clotting time in patients treated with coumarin drugs. Prothrombin time; whole blood clotting times in plain glass and in silicone coated tubes; Correlation between the silicone clotting...

  • Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Hein, O. Vargas; von Heymann, C.; Lipps, M.; Ziemer, S.; Ronco, C.; Neumayer, H. H.; Morgera, S.; Welte, M.; Kox, W. J.; Spies, C. // Intensive Care Medicine;Apr2001, Vol. 27 Issue 4, p673 

    Objective: To compare the efficacy and safety of hirudin and heparin for anticoagulation during continuous renal replacement therapy (CRRT) in critically ill patients. Design: Prospective, randomized controlled pilot study. Setting: Single centre; interdisciplinary intensive care unit at a...

  • Prinzipien des perioperativen Gerinnungsmanagements. Ganter, M.T.; Hofer, C.K. // Der Chirurg;Jul2011, Vol. 82 Issue 7, p635 

    The coagulation system is a complex network of interacting proteins and cells with extensive sensitivity, amplification and control pathways. The system represents a delicate balance between procoagulant and anticoagulant as well as profibrinolytic and antifibrinolytic activities. Clinically...

  • Direct Thrombin Inhibitors. O’Brien, P. Joshua; Mureebe, Leila // Journal of Cardiovascular Pharmacology & Therapeutics;Mar2012, Vol. 17 Issue 1, p5 

    Cardiovascular disease is a leading cause of death and pathologic coagulation plays an integral role in the development, propagation, and intervention of cardiovascular disease. The 2 classic anticoagulants, heparin and vitamin K antagonists, though having served humanity for nearly a century,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics